• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莫氏手术治疗皮肤恶性附属器肿瘤患者的疾病特异性生存率提高:一项全国性数据库研究

Enhanced Disease-Specific Survival Among Individuals With Malignant Adnexal Tumors of the Skin Treated With Mohs Surgery: A National Database Study.

作者信息

Taylor Mitchell A, Swedek Michelle, Halloran Peter, Georgesen Corey, Voss Vanessa B, Wysong Ashley

机构信息

School of Medicine, Creighton University, Omaha, Nebraska.

Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska.

出版信息

Dermatol Surg. 2025 Jan 1;51(1):11-16. doi: 10.1097/DSS.0000000000004397. Epub 2024 Sep 11.

DOI:10.1097/DSS.0000000000004397
PMID:39258783
Abstract

BACKGROUND

Malignant adnexal tumors of the skin are a rare group of tumors that can be locally aggressive and require surgical excision with strict margin control to achieve clearance. Given the rarity of these tumors, there is a limited understanding within the medical community regarding optimal treatment approaches.

OBJECTIVE

To examine surgical management trends and outcomes for patients diagnosed with cutaneous adnexal tumors from 2000 to 2020.

MATERIALS AND METHODS

The Surveillance, Epidemiology, and End Results database was queried to identify biopsy-proven cases of cutaneous adnexal tumors between 2000 and 2020. Clinical and disease characteristics were examined, and disease-specific survivals were compared between surgical approaches using Kaplan-Meier curves and Cox proportional hazards models.

RESULTS

Mohs surgery demonstrated a significant increase in utilization from 2000 to 2020 (+447.1%) and improvements in disease-specific survival (mean 231.7 months; p < .001) compared with no surgery; wide local excision exhibited no improved disease-specific survival (227.7 months; p = .070). Multivariable Cox regression further highlighted that only Mohs surgery exhibited a reduced disease-specific mortality risk compared with no surgery (adjusted HR 0.49; p = .011).

CONCLUSION

Given the enhanced disease-specific survival coupled with tissue preservation strategies, Mohs surgery emerges as a promising surgical approach for the treatment of malignant adnexal tumors of the skin.

摘要

背景

皮肤恶性附属器肿瘤是一组罕见的肿瘤,具有局部侵袭性,需要进行手术切除并严格控制切缘以实现清除。鉴于这些肿瘤的罕见性,医学界对最佳治疗方法的了解有限。

目的

研究2000年至2020年诊断为皮肤附属器肿瘤患者的手术治疗趋势和结果。

材料与方法

查询监测、流行病学和最终结果数据库,以识别2000年至2020年间经活检证实的皮肤附属器肿瘤病例。检查临床和疾病特征,并使用Kaplan-Meier曲线和Cox比例风险模型比较不同手术方法之间的疾病特异性生存率。

结果

与未手术相比,Mohs手术在2000年至2020年间的使用率显著增加(+447.1%),疾病特异性生存率有所提高(平均231.7个月;p < .001);广泛局部切除的疾病特异性生存率没有提高(227.7个月;p = .070)。多变量Cox回归进一步强调,与未手术相比,只有Mohs手术表现出降低的疾病特异性死亡风险(调整后HR 0.49;p = .011)。

结论

鉴于疾病特异性生存率提高以及组织保存策略,Mohs手术成为治疗皮肤恶性附属器肿瘤的一种有前景的手术方法。

相似文献

1
Enhanced Disease-Specific Survival Among Individuals With Malignant Adnexal Tumors of the Skin Treated With Mohs Surgery: A National Database Study.莫氏手术治疗皮肤恶性附属器肿瘤患者的疾病特异性生存率提高:一项全国性数据库研究
Dermatol Surg. 2025 Jan 1;51(1):11-16. doi: 10.1097/DSS.0000000000004397. Epub 2024 Sep 11.
2
Malignant Cutaneous Adnexal Tumors and Role of SLNB.皮肤附件恶性肿瘤和 SLNB 的作用。
J Am Coll Surg. 2021 Jun;232(6):889-898. doi: 10.1016/j.jamcollsurg.2021.01.019. Epub 2021 Mar 13.
3
Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes.具有外分泌分化的皮肤附件癌切除术后的生存:风险因素和结局趋势。
J Surg Oncol. 2013 Jul;108(1):57-62. doi: 10.1002/jso.23346. Epub 2013 May 16.
4
Surgical management of localized melanoma: a national cancer database retrospective review.局限性黑色素瘤的手术治疗:一项国家癌症数据库回顾性研究
Br J Dermatol. 2019 Oct;181(4):832-833. doi: 10.1111/bjd.17901. Epub 2019 Jul 25.
5
The risk of lymph node involvement in malignant cutaneous adnexal tumors.恶性皮肤附属器肿瘤发生淋巴结转移的风险。
Am Surg. 2014 Mar;80(3):270-4.
6
Factors associated with the utilization of Mohs micrographic surgery in the treatment of microcystic adnexal carcinoma.
J Am Acad Dermatol. 2019 Aug;81(2):640-642. doi: 10.1016/j.jaad.2019.01.069. Epub 2019 Feb 2.
7
Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database.在国家癌症数据库中,与广泛局部切除相比,接受 Mohs 显微外科手术治疗的 I 期和 II 期 Merkel 细胞癌的患者特征和结局。
J Am Acad Dermatol. 2018 Jul;79(1):126-134.e3. doi: 10.1016/j.jaad.2018.01.041. Epub 2018 Feb 3.
8
Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.Mohs 显微外科手术与广泛局部切除术治疗躯干和四肢黑色素瘤患者总生存结局的相关性。
JAMA Dermatol. 2021 Jan 1;157(1):84-89. doi: 10.1001/jamadermatol.2020.3950.
9
Improved Margin Control of Microcystic Adnexal Carcinoma After Mohs Micrographic Surgery Compared With Wide Local Excision.与广泛局部切除相比,Mohs显微外科手术后微囊性附属器癌的切缘控制得到改善。
Dermatol Surg. 2023 Apr 1;49(4):317-321. doi: 10.1097/DSS.0000000000003705. Epub 2023 Jan 27.
10
Behavior of Cutaneous Adnexal Malignancies: a Single Institution Experience.皮肤附件恶性肿瘤的行为:单机构经验。
Pathol Oncol Res. 2020 Jan;26(1):239-244. doi: 10.1007/s12253-018-0427-3. Epub 2018 Jun 14.

引用本文的文献

1
Mohs Micrographic Surgery and Improved Survival in Skin Cancer: A Narrative Review.莫氏显微外科手术与皮肤癌生存率的提高:一项叙述性综述。
Dermatol Ther (Heidelb). 2025 Jun;15(6):1283-1306. doi: 10.1007/s13555-025-01410-5. Epub 2025 Apr 20.
2
PRAME positive spiradenocarcinoma treated with Mohs micrographic surgery.采用莫氏显微外科手术治疗的PRAME阳性汗腺癌
JAAD Case Rep. 2025 Feb 17;59:22-25. doi: 10.1016/j.jdcr.2025.01.022. eCollection 2025 May.